CWIEX
Price
$80.56
Change
-$0.05 (-0.06%)
Updated
Jul 2 closing price
Net Assets
159.53B
MWEBX
Price
$34.61
Change
+$0.49 (+1.44%)
Updated
Jul 2 closing price
Net Assets
1.45B
Interact to see
Advertisement

CWIEX vs MWEBX

CWIEX vs MWEBX Comparison Chart in %
View a ticker or compare two or three
VS
CWIEX vs. MWEBX commentary
Jul 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIEX is a Buy and MWEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIEX has more cash in the bank: 160B vs. MWEBX (1.45B). CWIEX pays higher dividends than MWEBX: CWIEX (1.12) vs MWEBX (0.00). CWIEX was incepted earlier than MWEBX: CWIEX (24 years) vs MWEBX (40 years). MWEBX (1.97) is less costly to investors than CWIEX (1.00). CWIEX is a more actively managed with annual turnover of: 44.00 vs. MWEBX (17.00). CWIEX has a lower initial minimum investment than MWEBX: CWIEX (250) vs MWEBX (1000). CWIEX annual gain was more profitable for investors over the last year : 15.39 vs. MWEBX (-16.20). CWIEX return over 5 years is better than : 33.50 vs. MWEBX (-36.38).
CWIEXMWEBXCWIEX / MWEBX
Total Expense Ratio1.001.9252%
Annual Report Gross Expense Ratio1.001.9751%
Fund Existence24 years40 years-
Gain YTD14.0741.2281,146%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets160B1.45B11,034%
Annual Yield % from dividends1.120.00-
Returns for 1 year15.39-16.20-95%
Returns for 3 years47.19-20.55-230%
Returns for 5 years33.50-36.38-92%
Returns for 10 years115.976.191,873%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX50.741.87
+3.83%
ProFunds Biotechnology UltraSector Svc
DFSPX17.050.24
+1.43%
DFA Intl Sustainability Core 1
FNCRX41.070.55
+1.36%
Franklin Natural Resources C
RMEBX64.300.40
+0.63%
American Funds American Mutual R-2E
GMICX22.40N/A
N/A
GMO International Equity II